XenoPort Inc (XNPT)

7.07
0.05 0.71
Prev Close 7.02
Open 7.04
Day Low/High 7.02 / 7.07
52 Wk Low/High 3.35 / 7.86
Volume 2.62M
Avg Volume 1.64M
Exchange
Shares Outstanding 63.53M
Market Cap 449.13M
EPS -1.30
Div & Yield N.A. (N.A)
Stockholders Elect ALL Three XenoPort Director Nominees At Annual Meeting

Stockholders Elect ALL Three XenoPort Director Nominees At Annual Meeting

XenoPort, Inc. (Nasdaq: XNPT) today announced that, based on the estimated vote count provided by its proxy solicitor, stockholders have elected by a wide margin all of the XenoPort director nominees at the ...

XenoPort To Present At The 2014 Wells Fargo Healthcare Conference

XenoPort To Present At The 2014 Wells Fargo Healthcare Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2014 Wells Fargo Healthcare Conference.

XenoPort Urges Stockholders To Vote "FOR ALL" XenoPort Director Nominees On The WHITE Proxy Card

XenoPort Urges Stockholders To Vote "FOR ALL" XenoPort Director Nominees On The WHITE Proxy Card

XenoPort, Inc. (Nasdaq:XNPT) today reminded stockholders to vote at the Company’s upcoming Annual Meeting of Stockholders on June 11, 2014.

XenoPort Mails Letter To Stockholders Highlighting ISS’s Recommendation That XenoPort Stockholders Vote “FOR ALL” Of XenoPort’s Director Nominees On The WHITE Card

XenoPort Mails Letter To Stockholders Highlighting ISS’s Recommendation That XenoPort Stockholders Vote “FOR ALL” Of XenoPort’s Director Nominees On The WHITE Card

XenoPort, Inc. (Nasdaq: XNPT) today announced that it is mailing a letter to stockholders in connection with the Company's upcoming Annual Meeting, which will be held on June 11, 2014.

Second Independent Proxy Advisory Firm Recommends That XenoPort Stockholders Vote “FOR ALL” XenoPort Director Nominees On The WHITE Proxy Card

Second Independent Proxy Advisory Firm Recommends That XenoPort Stockholders Vote “FOR ALL” XenoPort Director Nominees On The WHITE Proxy Card

XenoPort, Inc. (Nasdaq: XNPT) today announced that Egan-Jones Proxy Services, an independent proxy advisory firm, has recommended that XenoPort stockholders vote “ FOR ALL” of XenoPort’s director ...

XenoPort To Present New Pooled Data Analyses On HORIZANT (gabapentin Enacarbil) At The 2014 SLEEP Annual Meeting

XenoPort To Present New Pooled Data Analyses On HORIZANT (gabapentin Enacarbil) At The 2014 SLEEP Annual Meeting

XenoPort, Inc. (Nasdaq:XNPT) announced today that new pooled data analyses for gabapentin enacarbil, the active ingredient of HORIZANT ® (gabapentin enacarbil) Extended-Release Tablets, will be presented at the...

Leading Independent Proxy Advisory Firm ISS Recommends XenoPort Stockholders Vote FOR ALL XenoPort Director Nominees

Leading Independent Proxy Advisory Firm ISS Recommends XenoPort Stockholders Vote FOR ALL XenoPort Director Nominees

XenoPort, Inc. (Nasdaq: XNPT) today announced that Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, has recommended that XenoPort stockholders vote “FOR ALL” of ...

XNPT: Insiders vs. Shorts

XNPT: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 04/30/2014 settlement date, and XenoPort Inc is one of the most shorted stocks of the Russell 3000, based on 9.37 "days to cover" versus the median component at 5.62. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

XenoPort To Present At The Jefferies 2014 Global Healthcare Conference

XenoPort To Present At The Jefferies 2014 Global Healthcare Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Jefferies 2014 Global Healthcare Conference.

XenoPort Files Investor Presentation

XenoPort Files Investor Presentation

XenoPort, Inc. (Nasdaq: XNPT) today announced that it has filed a presentation with the U.

XenoPort To Mail Letter To Stockholders

XenoPort To Mail Letter To Stockholders

XenoPort, Inc. (Nasdaq: XNPT) today announced that it is mailing a letter to stockholders in connection with the Company’s upcoming Annual Meeting, which will be held on June 11, 2014.

3 Stocks Under $10 Moving Higher

3 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

(Graphic: Business Wire)

(Graphic: Business Wire)

XenoPort, Inc. (Nasdaq:XNPT) today announced that it is mailing a letter to stockholders in connection with the Company’s upcoming Annual Meeting, which will be held on June 11, 2014.

XenoPort Reports First Quarter Financial Results

XenoPort Reports First Quarter Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2014.

XenoPort To Release First Quarter Financial Results On May 8, 2014

XenoPort To Release First Quarter Financial Results On May 8, 2014

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 8, 2014 at approximately 4:30 p.

XenoPort Presents New Analyses Of Data For Gabapentin Enacarbil At The 33rd Annual Scientific Meeting Of The American Pain Society

XenoPort Presents New Analyses Of Data For Gabapentin Enacarbil At The 33rd Annual Scientific Meeting Of The American Pain Society

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will present new analyses of data for gabapentin enacarbil (GEn), the active ingredient in HORIZANT ® (gabapentin enacarbil) Extended-Release Tablets, at the...

XenoPort To Present New Data For Novel Fumarate Analog XP23829 And HORIZANT At The 66th Annual Meeting Of The American Academy Of Neurology

XenoPort To Present New Data For Novel Fumarate Analog XP23829 And HORIZANT At The 66th Annual Meeting Of The American Academy Of Neurology

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will present data on its investigational and marketed therapies for neurological diseases at the 66 th Annual Meeting of the American Academy of Neurology (AAN) in...

XenoPort Files Definitive Proxy Materials And Mails Letter To Stockholders

XenoPort Files Definitive Proxy Materials And Mails Letter To Stockholders

XenoPort, Inc. (Nasdaq: XNPT) today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with the Company’s 2014 Annual Meeting of Stockholders.

XenoPort Enters Oversold Territory (XNPT)

XenoPort Enters Oversold Territory (XNPT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of XNPT May 17th Options Trading

First Week of XNPT May 17th Options Trading

Investors in XenoPort Inc saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XNPT options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

Short Interest Makes 17.8% Move For XNPT

Short Interest Makes 17.8% Move For XNPT

The most recent short interest data has been released by the NASDAQ for the 02/14/2014 settlement date, which shows a 658,060 share increase in total short interest for XenoPort Inc , to 4,348,280, an increase of 17.83% since 01/31/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting XNPT Put And Call Options For April 19th

Interesting XNPT Put And Call Options For April 19th

Investors in XenoPort Inc saw new options begin trading this week, for the April 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XNPT options chain for the new April 19th contracts and identified one put and one call contract of particular interest.

XenoPort To Present At The Cowen And Company 34th Annual Health Care Conference

XenoPort To Present At The Cowen And Company 34th Annual Health Care Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2014 Cowen and Company 34th Annual Health Care Conference.

XenoPort Reports Fourth Quarter And Year-End 2013 Financial Results

XenoPort Reports Fourth Quarter And Year-End 2013 Financial Results

XenoPort, Inc. (Nasdaq:XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2013.

XenoPort To Present At The RBC Capital Markets’ Global Healthcare Conference

XenoPort To Present At The RBC Capital Markets’ Global Healthcare Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the RBC Capital Markets’ Global Healthcare Conference.

RLS/WED Survey Of Patients’ Spouses And Partners Reveals Their Concern Of Disease-Related Burdens

RLS/WED Survey Of Patients’ Spouses And Partners Reveals Their Concern Of Disease-Related Burdens

The Willis-Ekbom Disease (WED) Foundation and XenoPort, Inc. (Nasdaq:XNPT) announced today the second phase of results from the “Patient Odyssey” survey, which reveals how Restless Legs ...

XenoPort To Release Fourth Quarter And Year-End Financial Results On February 20, 2014

XenoPort To Release Fourth Quarter And Year-End Financial Results On February 20, 2014

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its fourth quarter financial results on February 20, 2014 at approximately 4:30 p.

XenoPort Appoints Richard Kim, M.D., As Chief Medical Officer

XenoPort Appoints Richard Kim, M.D., As Chief Medical Officer

XenoPort, Inc. (Nasdaq:XNPT) announced today that Richard Kim, M.

XenoPort Announces Pricing Of Public Offering Of Common Stock

XenoPort Announces Pricing Of Public Offering Of Common Stock

XenoPort, Inc. (NASDAQ: XNPT) announced today the pricing of an underwritten registered public offering of 12,000,000 shares of its common stock at a price to the public of $6.

XenoPort Announces Proposed Public Offering Of Common Stock

XenoPort Announces Proposed Public Offering Of Common Stock

XenoPort, Inc. (Nasdaq: XNPT) announced today that it intends to offer and sell 10,000,000 shares of its common stock, subject to market and other conditions, in an underwritten public offering.